|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6B
|
|
pubmed:dateCreated |
2003-1-29
|
|
pubmed:abstractText |
To evaluate the efficacy and tolerability of irinotecan plus vinorelbine every 2 weeks in patients with advanced non-small cell lung cancer (NSCLC), previously treated with platinum-based chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3501-6
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12552946-Adult,
pubmed-meshheading:12552946-Aged,
pubmed-meshheading:12552946-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12552946-Camptothecin,
pubmed-meshheading:12552946-Carboplatin,
pubmed-meshheading:12552946-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12552946-Cisplatin,
pubmed-meshheading:12552946-Drug Resistance, Neoplasm,
pubmed-meshheading:12552946-Female,
pubmed-meshheading:12552946-Humans,
pubmed-meshheading:12552946-Lung Neoplasms,
pubmed-meshheading:12552946-Male,
pubmed-meshheading:12552946-Middle Aged,
pubmed-meshheading:12552946-Vinblastine
|
|
pubmed:articleTitle |
Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.
|
|
pubmed:affiliation |
1st Department of Medical Oncology, Metaxa's Memorial Cancer Hospital, Piraeus, Greece. pectasid@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
